Sangamo BioSciences appoints Geoffrey Nichol executive VP of R&D
This article was originally published in Scrip
Executive Summary
Sangamo BioSciences, a company focused on research and development of novel DNA-binding proteins for therapeutic gene regulation and modification, has appointed Dr Geoffrey Nichol executive vice-president of R&D. Dr Nichol most recently served as senior vice-president of product development at Medarex.